CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 Jan 2023 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

03 Jan 2023 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil

13 Dec 2022 17:45:52 By Nasdaq GlobeNewswire

Cytokinetics Stock Trading Halted Today

13 Dec 2022 07:02:16 By Nasdaq GlobeNewswire

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

09 Dec 2022 08:59:34 By Nasdaq GlobeNewswire

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

08 Dec 2022 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

07 Dec 2022 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Dec 2022 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND

01 Dec 2022 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022

07 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Reports Third Quarter 2022 Financial Results

03 Nov 2022 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Nov 2022 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American Heart Association Scientific Sessions 2022

31 Oct 2022 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics to Announce Third Quarter Results on November 3, 2022

20 Oct 2022 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis

10 Oct 2022 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Oct 2022 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting

02 Oct 2022 09:45:00 By Nasdaq GlobeNewswire

Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HCM Society Scientific Sessions

30 Sep 2022 10:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program

28 Sep 2022 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Upcoming Presentations at the 2022 Inaugural HCM Society Scientific Sessions and the HFSA Annual Scientific Meeting

26 Sep 2022 07:30:00 By Nasdaq GlobeNewswire